One Stop Shop for All Your Market Research Reports

Global Pain Management Therapeutics Market Threats, Analysis, Key Players, Growth, and Forecast 2026

North America to Dominate the Global Pain Management Therapeutics Market Over the Forecast Period. Pain treatment and drug options available for the general population include medication, therapeutics, and mind-body techniques. The number of patients suffering from chronic pain is rising at a substantially high pace globally each year. According to the World Health Organization (WHO), approximately 176 million people were suffering from chronic pain in 2016 in the U.S. alone, and around 1 in 5 individuals in Europe suffer from chronic pain at some point of the year. The global geriatric population has been increasing significantly over the past decade and is a key driver for growth of the global pain management therapeutics market. In addition, early onset of aging is another factor driving demand for pain management therapeutics and treatments. Increasing age-related diseases such as diabetic neuropathy, nerve damage, depression, epilepsy, bone or joint pain, and injuries etc. has been witnessing a significant increase in the recent past. Moreover, rising number of patients suffering from chronic diseases and growing adoption of pain management therapeutics is further driving growth of the global pain management therapeutics market at an exponential rate. However, patent expiry on major pain management drugs is a key factor restraining growth of the global pain management therapeutics market. In addition, availability of generic pain management drugs is another major factor expected to hamper growth of the global pain management therapeutics market. The global pain management therapeutics market report has been segmented on the basis of therapeutics, indication, and region. On the basis of therapeutics, the global pain management therapeutics market is segmented into Anticonvulsants, Antidepressants, Anaesthetics, Non-steroidal Anti-inflammatory Drugs (NSAIDS), Opioids, Antimigraine agents and, Other Non-Narcotic Analgesic. On the basis of indication, Neuropathic Pain, Fibromyalgia, Chronic Back Pain, Arthritic Pain, Migraine, Post-operative Pain and, Cancer Pain. On the basis of region, the report is segmented as North America, Europe, Asia Pacific, and Middle East & Africa. North America dominated the global pain management therapeutics market in terms of revenue share, owing to presence of appropriate healthcare infrastructure and extensive consumption of high-end pain management drugs. Europe accounted for the second largest share of the global pain management therapeutics market in terms of revenue share, due to increasing use of pain management drugs by the general population followed by Asia Pacific. Emerging economies such as Japan and China are expected to expand at the highest CAGR of X.X% over the forecast period, owing to rise in ageing population and infrastructure development in the regions. Global pain management therapeutics market segmentation by therapeutics:
  • Anticonvulsants
  • Antidepressants
  • Anesthetics
  • Non-steroidal Anti-inflammatory Drugs (NSAIDS)
  • Opioids
    • Oxycodones
    • Hydrocodones
    • Tramadol
    • Others (Morphine, Codeine, Fentanyl, Meperidine, Methadone)
  • Antimigraine Agents
  • Other Non-Narcotic Analgesic
Global pain management therapeutics market segmentation by indication:
  • Neuropathic Pain
  • Fibromyalgia
  • Chronic Back Pain
  • Arthritic Pain
  • Migraine
  • Post-operative Pain
  • Cancer Pain
Global pain management therapeutics market segmentation by region:
  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • Middle East & Africa
Key players in the global pain management therapeutics market include,
  • Abbott Laboratories
  • AstraZeneca
  • Depomed, Inc.
  • Endo Pharmaceuticals, Inc.
  • GlaxoSmithKline plc
  • Johnson & Johnson
  • Mallinckrodt Pharmaceuticals
  • Merck & Co., Inc.
  • Novartis AG
  • Pfizer, Inc.
  • Purdue Pharma L.P.
  • Teva Pharmaceutical Industries Limited
Report Structure: In the first section of the report we offer a table of content, followed by a list of figures. The next section offers a definition and brief explanation of the various products and segmentation of the target market, along with research methodology and a list of acronyms and sources used to gather and analyse data and information. The third section of the report entails a brief list of drivers, restraints, opportunities, and threats (DROTs) in the target market. The report also offers insights on various trends in regions, countries, and markets as per segmentation, as well as insights and crucial information obtained from various sources including primary and secondary, annual reports, the Internet and others. The final section comprises detailed profiles of key players in the target market and a SWOT analysis of each company, apart from strategies, acquisitions and mergers. Objective of Report: Sections of the report are created and designed specifically to offer readers a clear, clean, and insights into historical, estimated, and revenue (US$ Mn/Bn) estimation and projection, Compounded Annual Growth Rate (CAGR %), and volume in measure as applicable to the target product/market. We offer illustrations, charts, tables, and figures to support our findings and analysis, in addition to key finding for markets in regions and countries. This report is valuable asset for the existing players, new entrants and the future investors. Who we are and what we do: Market.biz is a pioneering company in the fields of market research and analytical reporting. Our services enable clients to enhance business efficiency and focus on other core aspects of operations, while we take care of market research and reporting needs. Market.biz conducts and executes detailed and in-depth research and analysis across all relevant domains and offers accurate and insightful estimations and forecasts to enable clients to take well-informed and crucial decisions in their respective industries, sectors, or companies. Market.biz has access to the world’s most comprehensive and up-to-date databases in any business sector, as we understand the specific and varying needs of our clients. We offer updated reports to keep up with the changing scenarios in global markets and strive to ensure that only the utmost quality is established and maintained in every single report we produce. Our reports are conveniently designed and structured and are visually-pleasing. We provide a detailed analysis outlook of competitive markets and identify and study new and emerging trends and other crucial aspects and factors impacting or driving market growth. We also offer insights regarding new and emerging opportunities in the market and present the information in a comprehensive report focused on your respective market or sector.
Request for Table of Contents

Inquiry Before Buying

Request Sample

Share This Report

Our Clients

Payment Mode
Single User US $ $ 4395
Multi User US $6395
Corporate User US $9395
About this Report
Report ID 148290
Category
  • Pharmaceuticals and Healthcare
Published on Upcoming
Number of Pages NA
Publisher Name Prudour
Editor Rating
★★★★★
★★★★★
(0)